Srivastava Anita, Kahan Meldon
Centre for Addiction and Mental Health, Department of Family and Community Medicine, University of Toronto, ON, M5S 2S1, Canada.
J Addict Dis. 2006;25(3):5-13. doi: 10.1300/J069v25n03_02.
To review the literature on methadone deaths and propose evidence-based dosing guidelines.
A literature search was conducted on overdose deaths during the induction phase. Data on methadone deaths from the Ontario coroner's office, as well as prescribing guidelines from different countries and jurisdictions, were reviewed. The information was collectively considered and, using the best available evidence, translated into safe dosing guidelines for methadone induction.
A literature review found high death rates during the methadone induction period. Data from the Ontario coroner's office revealed that of deaths that were felt to be attributable to methadone overdose, the majority occurred in those who had consumed diverted methadone: of those deaths within a registered program, the majority occurred during the initial dosing phase. Despite high death rates during induction onto methadone treatment, many jurisdictions do not have prescribing guidelines that take this evidence into account.
Safer prescribing guidelines are needed to reduce deaths during induction onto methadone treatment. Recommendations are made for safe methadone induction doses.
回顾关于美沙酮致死的文献并提出基于证据的剂量指南。
对诱导期过量致死情况进行文献检索。查阅了安大略省验尸官办公室关于美沙酮致死的数据以及不同国家和司法管辖区的处方指南。综合考虑这些信息,并利用现有最佳证据,转化为美沙酮诱导的安全剂量指南。
文献综述发现美沙酮诱导期死亡率很高。安大略省验尸官办公室的数据显示,在被认为归因于美沙酮过量的死亡案例中,大多数发生在服用了被挪用美沙酮的人群中:在注册项目内的死亡案例中,大多数发生在初始给药阶段。尽管美沙酮治疗诱导期死亡率很高,但许多司法管辖区的处方指南并未考虑到这一证据。
需要更安全的处方指南以降低美沙酮治疗诱导期的死亡率。针对美沙酮诱导的安全剂量提出了建议。